Anteilseigner
Alexander K. Arrow (1,03 %) David A. Lovejoy (0,84 %) The Vanguard Group, Inc. (0,72 %) Geode Capital Management LLC (0,57 %) Osaic Wealth, Inc. (Investment Management) (0,48 %) FNY Capital Management LP (0,42 %) SSgA Funds Management, Inc. (0,31 %) Tower Research Capital LLC (0,13 %) Vanguard Global Advisers LLC (0,03 %) Wells Fargo Bank, NA (Private Banking) (0,00 %)
Kontakt
Protagenic Therapeutics Inc.
5th Avenue, Room 500 149
10010-6826 New York